Edwards Lifesciences Corp at Wells Fargo Healthcare Conference Transcript
All right. Good morning, everyone. I'm Larry Biegelsen, the medical device analyst at Wells Fargo. And it's my pleasure to host this session with the management team from Edwards Lifesciences. With us, we have Mike Mussallem, Chairman and CEO; and Scott Ullem, Corporate Vice President and Chief Financial Officer; as well as Mark Wilterding, Vice President of Investor Relations. In terms of the format, it's going to be a fireside chat. If anyone has a question in the audience, please raise your hand and we will call on you. So Mike and Scott, thank you very much for being here again this year. Really appreciate it.
Great.
Questions & Answers
So Mike, I thought we'd start kind of at a high level. It seems like Edwards is poised for strong continued growth in the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |